Physician profile
Llewellyn V Lee
NPI 1669444212
$78,440.39
in general payments reported to CMS, 2019-2025
27 companies · $1,991 in 2025
The $1,991 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40K · 2020: $13K · 2021: $13K · 2022: $5,544 · 2023: $3,834 · 2024: $1,226 · 2025: $1,991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,251 · Consulting Fee: $2,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,251.12 |
| Consulting Fee | $2,800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $27,361.18 | 2019-2020 | |
| Covidien LP | $23,100.00 | 2019-2020 | |
| Medtronic, INC. | $18,353.24 | 2021-2025 | Venaseal, Endurant Iis, Turbohawk |
| Terumo Medical Corporation | $3,776.57 | 2020-2025 | Azur Cx Detachable, Glidesheath Slender, Metacross Otw |
| Cardiovascular Systems INC. | $1,278.88 | 2019-2023 | Diamondback Peripheral |
| Philips North America LLC | $1,024.78 | 2021-2025 | (Az7) Lasers, IV Other, Labosys |
| Tactile Systems Technology INC | $951.76 | 2021-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Abbott Laboratories | $470.37 | 2021-2025 | Esprit, Diamondback Peripheral, Emboshield Nav6 |
| W. L. Gore & Associates, INC. | $469.14 | 2021-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Endoprosthesis With Heparin, Gore Viabahn Vbx Balloon Expandable Endo |
| Bard Peripheral Vascular, INC. | $357.34 | 2019-2024 | Lutonix Drug Coated Balloon |
| Asahi Intecc USA, INC. | $336.63 | 2021-2023 | Asahi Ptca Guide Wire |
| Cook Medical LLC | $276.23 | 2022-2024 | Rosen, Tornado, Torcon Nb |
| Biotronik INC. | $123.34 | 2022 | |
| Angiodynamics, INC. | $119.73 | 2021 | |
| Inari Medical, INC. | $91.43 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $85.14 | 2022 | |
| Teleflex LLC | $46.70 | 2024-2025 | D-Stat, Vsi |
| Boston Scientific Corporation | $43.14 | 2022-2025 | Varithena Administration Pack |
| Cordis US Corp. | $24.03 | 2023 | Mynxgrip |
| Melinta Therapeutics, LLC | $23.64 | 2025 | Kimyrsa, Rezzayo |
| Mallinckrodt Hospital Products INC. | $22.12 | 2021 | |
| Inspiremd LTD | $20.63 | 2025 | Cguard Prime Carotid Stent System |
| Neuros Medical, INC. | $19.18 | 2025 | Altius |
| Pfizer INC. | $18.45 | 2022 | |
| Cagent Vascular INC | $16.73 | 2025 | Serrantor |
| Averitas Pharma INC. | $15.19 | 2024 | Qutenza |
| Becton, Dickinson and Company | $14.82 | 2025 | Tridyne Vascular Sealant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Llewellyn Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.